ABSTRACT Airway cellular dysfunction is a differentiating feature of severe asthma in children that may be related to an imbalance of the antioxidant, glutathione (GSH). We hypothesized that

oxidation of GSH to glutathione disulfide (GSSG) in the epithelial lining fluid (ELF) of children with severe asthma would contribute to altered airway macrophage (AM) GSH homeostasis and

AM cellular dysfunction. Bronchoalveolar lavage (BAL) was performed in 64 asthmatic children (severe asthma, _n_ = 43). GSH, GSSG, markers of lipid peroxidation and DNA oxidation, and IL-8

were quantified in the BAL supernatant. GSH, GSSG, activities of histone deacetylase (HDAC) and histone acetyltransferase, apoptosis, and phagocytosis were assessed in isolated AMs. Children

children with severe asthma. Severe asthma in children is characterized by altered airway and intracellular AM GSH homeostasis that translates to impaired AM function. Interventions to

restore airway GSH homeostasis may be warranted in children with severe asthma. SIMILAR CONTENT BEING VIEWED BY OTHERS THE ROLE OF OXIDISED SELF-LIPIDS AND ALVEOLAR MACROPHAGE CD1B

EXPRESSION IN COPD Article Open access 18 February 2021 S100A9 IN ADULT ASTHMATIC PATIENTS: A BIOMARKER FOR NEUTROPHILIC ASTHMA Article Open access 20 July 2021 INCREASED AIRWAY IRON

PARAMETERS AND RISK FOR EXACERBATION IN COPD: AN ANALYSIS FROM SPIROMICS Article Open access 29 June 2020 MAIN Severe or “difficult-to-treat” asthma in children is a complicated disorder

associated with a high degree of morbidity. Although the pathophysiology of severe asthma in children is not entirely understood, symptoms are thought to result from persistent airway

inflammation and oxidant stress that are not attenuated with corticosteroid treatment (1,2). This unopposed cycle of airway inflammation and oxidant stress ultimately contributes to

irreversible airway injury (3), which further increases the frequency and severity of symptoms (1). Glutathione (GSH) is a thiol antioxidant that is highly expressed in the epithelial lining

fluid (ELF) and within airway cells (4,5), where it functions as a regulator of the cell cycle and enzyme substrate (6). With exposure to hydroperoxides, GSH becomes oxidized, forming

glutathione disulfide (GSSG). Although acute changes in the GSH to GSSG ratio are necessary for the detoxification of reactive oxygen species, chronic GSSG formation can inhibit the

antioxidant capabilities of the airways through depletion of the total GSH pool (7). This altered ratio of GSH to GSSG further promotes histone acetylation by increasing histone

acetyltransferase (HAT) activity and inhibiting histone deacetylase (HDAC) activity in airway cells, leading to enhanced release of proinflammatory cytokines, such as IL-8 (8). This

mechanism may account for the airway hyperresponsiveness and dysfunction previously observed in ovalbumin-sensitized mice, which is abrogated with GSH supplementation and restoration of the

GSH/GSSG balance in airway tissue (9). Although the precise role of GSH in asthma severity is unclear, low GSH and increased GSSG concentrations have been reported in the exhaled breath (10)

and ELF (2) of asthmatic children. Although corticosteroid treatment normalizes the airway GSH to GSSG ratio in mild-to-moderate asthmatic children with acute exacerbations (10), children

with severe asthma have marked depletion of GSH, increased GSSG formation, and increased lipid peroxidation in the airways despite high-dose corticosteroid therapy (2). Given the vital role

of GSH in maintaining cellular processes, altered airway GSH homeostasis in children with severe asthma may have profound implications for vital airway functions, including innate immune

defenses against foreign pathogens (11). Indeed, we have previously observed significant alterations of airway macrophage (AM) function in children with severe asthma, including increased

proinflammatory cytokine and chemokine release, increased apoptosis, and impaired phagocytosis of infectious particles (12). Therefore, the purpose of this study was to quantify GSH

homeostasis in both the ELF and AMs of children with severe _versus_ moderate asthma. We hypothesized that increased oxidation of GSH in the ELF would result in a shift in the AM

intracellular GSH to GSSG ratio and AM cellular dysfunction. METHODS SAMPLE. This study was approved by the Emory University Institutional Review Board. Informed consent was obtained from

all participating children and their legal guardians. Children also provided written and verbal assent. Recruitment was limited to children, 6–18 y of age with physician-diagnosed asthma

undergoing bronchoscopy for clinical indications. All children had persistent asthma (13) with a history of at least a 12% change in the forced expiratory volume in 1 second (FEV1) after

bronchodilator administration. All children were treated with a stable dose of inhaled corticosteroid (ICS) for at least 6 wk before enrollment. Severe asthma was diagnosed according to

criteria developed by the National Heart, Lung and Blood Institute's Severe Asthma Research Program (1), which were adapted from the American Thoracic Society's Workshop Report

(14). Severe asthma was diagnosed in children treated with high-dose ICS or daily oral corticosteroids who also had two minor criteria (1). Thresholds for high-dose ICS were defined as ≥440

μg of fluticasone equivalent per day for children <12 y and ≥880 μg for children, 12–18 y of age. Children who did not meet criteria for severe asthma were classified as having moderate

asthma given the extent of symptoms and current treatment with ICS (13). For diagnostic purposes, children with moderate and severe asthma underwent flexible bronchoscopy with

bronchoalveolar lavage (BAL) as indicated for persistent asthma symptoms despite ICS treatment. Seven children with moderate asthma also underwent bronchoscopy for suspected foreign body

aspiration (_n_ = 2) and recurrent pneumonia (_n_ = 5). All children were clinically stable at the time of bronchoscopy with no evidence of an acute upper respiratory tract infection,

including no rhinorrhea and no increase in chest symptoms or short-acting bronchodilator use for 2 wk before the procedure. The BAL return volume was divided between the research and

clinical laboratories. The samples submitted to the clinical laboratories were subjected to standard culture and sensitivity testing, viral respiratory panels, and cytopathological stains

for bacteria and fungi. PROCEDURES. Spirometry was performed with a portable spirometer (KoKo Legend, Ferraris, Louisville, CO) (15), and the best of three forced vital capacity (FVC)

maneuvers was interpreted (16). Venipuncture was performed immediately before bronchoscopy. Bronchoscopy was performed under general anesthesia using a laryngeal mask airway and flexible

bronchoscope (Olympus BF-3C160; Olympus America Inc., Melville, NY). BAL fluid was collected from the right middle lobe with three 1 mL/kg (50 mL maximum) saline lavages. Blood and BAL

samples were centrifuged at 5000 and 1200 rpm, respectively, for 7–10 min. To prevent auto-oxidation before GSH and GSSG analysis, 250 μL of BAL supernatant was immediately added to an equal

volume of 5% perchloric acid preservation solution containing iodoacetic acid (6.7 μm) and boric acid (0.1 mol/L) with 5 μm γ-glutamyl-glutamate and immediately frozen at −80°C (17). Total

cell counts were performed with a hemocytometer, and cellular differentials were determined from 300 consecutive cells after Diff-Quick staining. Cell pellets with <85% AM purity were

excluded from further analysis. AMs were purified from the cell pellet by adherence to plastic. The cell pellet was resuspended in 10 mL of 1:1 DMEM/Ham's F-12 containing 2% bovine

serum. One aliquot of re-suspended AMs was preserved for GSH and GSSG analysis. Another aliquot was treated with protease inhibitors and immediately frozen at −80°C for HDAC, HAT, and IL-8

analysis. The other AMs were added to glass chamber slides containing 100 μL medium with or without 500 μm GSH. The AMs were incubated at 37°C with 10% carbon dioxide for 15 h, after which

fluorescein isothiocyanate-conjugated inactived _Staphylococcus aureus_ (Invitrogen, Carlsbad, CA) was added in a 10:1 ratio and incubated for 2 h. Cells were fixed with 3.7%

para-formaldehyde and stored at 4°C. Urea nitrogen was measured in the plasma and BAL supernatant by a quantitative colorimetric assay (Pointe Scientific, Canton, MI) with a sensitivity of

0.05 to 150 mg/dL. The dilution of the BAL was calculated from [urea]plasma/[urea]BAL (18). The protein content of the BAL supernatant and AM cell lysate were determined using a Coomassie

protein assay (Pierce Biotechnology, Rockford, IL) with a detection limit of 1 μg/mL. GSH and GSSG were measured in the BAL supernatant and AM lysate as previously described (2) by HPLC

after derivatization of the samples with dansyl chloride (17). Derivatives were separated on a 10-μm Ultrasil amino-column with fluorescence detection at 365 nm (Waters Alliance 2690; Waters

Corporation, Milford, MA). GSH and GSSG were quantified relative to γ-glutamyl-glutamate by integration (19). Intracellular AM GSSG was also assessed in fixed AMs at baseline and after 500

μm GSH supplementation by immunostaining for GSH protein complexes [1:100 anti-GSH (D8); Santa Cruz Biotechnology, Santa Cruz, CA]. Relative fluorescent units were determined by quantitative

digital analysis from 10 fields using Image-Pro Plus for Windows (Version 3.1; Media Cybernetics, Inc., Silver Spring, MD). To further characterize the extent of lipid and DNA oxidation in

the BAL supernatant, malondialdehyde (MDA) concentrations were quantified using a commercially-available spectrophotometric assay (Bioxytech MDA-586; Oxis International, Foster City, CA)

with a sensitivity of 1 μm. Free and DNA-incorportated 8-hydroxy-2-deoxyguanosine (8-OH-dg) concentrations were measured by competitive assay using a mouse IgG-coated plate and 8-OH-dg

enzyme conjugate tracer with a detection limit of 30 pg/mL (Cayman Chemical, Ann Arbor, MI). HDAC and HAT activities were measured in the AM cell lysate using commercially available assay

kits (Abcam, Cambridge, MA; Cayman Chemical) at an excitation and emission of 360 and 450 nm, respectively. IL-8 was measured in the BAL supernatant and AM cell lysate by a bead-based assay

with a sensitivity of 0.11 pg/mL (Millipore, Billerica, MA). Data were analyzed using the BioRad Bio-Plex System (Bio-Rad Laboratories, Hercules, CA) with gates of 4,335 and 10,000. AM

phagocytosis was assessed as described previously (12) at baseline and after 500 μm GSH supplementation using an Olympus confocal microscope (model BX51; Olympus America Inc.) containing an

argon/krypton laser. AMs were analyzed from 10 separate fields by quantitative digital fluorescence imaging software (Olympus FluoView 300, Version 4.3). To ensure internalization of _S.

aureus_, laser confocal microscopy was performed at 50% of the AM depth using identical background and gain settings. AMs with bacterial inclusions were considered positive for phagocytosis.

A phagocytic index was calculated by multiplying the percentage of AMs undergoing phagocytosis by the average relative fluorescent units per phagocytic cell. Apoptosis at baseline and after

500 μm GSH supplementation was determined by immunostaining for cleavage of poly (ADP-ribose) polymerase (PARP) in fixed AMs using a 1:100 dilution of anti-PARP-1 (Santa Cruz

Biotechnology). Cellular fluorescence was determined by quantitative digital analysis using Image-Pro Plus for Windows (Version 3.1; Media Cybernetics, Inc.). Data were expressed as the

percentage of AMs fluorescently positive from 10 experimental fields per set. DATA ANALYSIS. Data analysis was performed with SPSS® software (Version 17; SPSS Inc., Chicago, IL). GSH, GSSG,

MDA, 8-OH-dg, and IL-8 were logarithmically transformed given their nonnormal distribution. Data were expressed in the raw BAL fluid and per milliliter of ELF according to the urea dilution

(18). AM lysate data were expressed per μg of protein. The _t_ tests and paired _t_ tests were performed for all between-group and within-group comparisons, respectively. Pearson correlation

coefficients were also used to determine associations between variables. Two-tailed tests were used with significance defined as α < 0.05. RESULTS Twenty-one children with moderate

asthma and 43 children with severe asthma were enrolled. Although five children with moderate asthma underwent bronchoscopy for recurrent pneumonia, these children were stable at the time of

enrollment and had no evidence of active airway infection, including negative viral respiratory panels and no evidence of bacterial airway colonization. Bronchoscopy with BAL was well

tolerated, and no child required overnight hospitalization or prolonged observation. Features of the groups are shown in Table 1. Children with severe asthma had increased markers of

allergic sensitization and were more likely to be of African American descent. Children with severe asthma also had increased airflow obstruction and greater healthcare utilization despite

more aggressive corticosteroid treatment. GSH HOMEOSTASIS, OXIDATIVE STRESS, AND INFLAMMATION IN THE ELF. There were no significant differences in BAL or ELF GSH concentrations between

groups. Although there were no significant differences in the total BAL or ELF GSH + GSSG pool between groups (BAL: median 1123 _versus_ 704 nmol/L, _p_ = 0.539; ELF: median 64 _versus_ 57

μm, _p_ = 0.207), children with severe asthma had significantly higher BAL and ELF concentrations of GSSG (Table 2). This was accompanied by increased lipid peroxidation and increased DNA

oxidation as measured by MDA and 8-OH-dg, respectively (Table 2). IL-8 was also increased in children with severe asthma (Table 2) and was strongly associated with the percentage of airway

neutrophils (_r_ = 0.452, _p_ = 0.001). GSH HOMEOSTASIS AND INFLAMMATION IN AMS. The imbalance in airway GSH homeostasis was also reflected at the cellular level. Although intracellular AM

concentrations of GSH were not different between groups (175 ± 120 nmol/L _versus_ 190 ± 255 nmol/L for severe _versus_ moderate asthma, _p_ = 0.283), children with severe asthma had higher

intracellular GSSG concentrations with an accompanying increase in the percentage of GSSG in the total intracellular GSH + GSSG pool (Fig. 1). Within the severe asthma group, stratification

by high intracellular GSSG (>250 nm/μg protein, _n_ = 7) _versus_ low intracellular GSSG (<250 nm/μg protein, _n_ = 16) revealed no significant differences in age, gender, race, ICS

dose, asthma medical history, healthcare utilization, and lung function or airway cellularity between groups, suggesting that clinical features alone were not responsible for the results.

However, intracellular GSSG concentrations did correlate with GSSG concentrations in the BAL supernatant (_r_ = 0.375, _p_ = 0.038) and ELF (_r_ = 0.322, _p_ = 0.05). No associations between

intracellular GSSG and the oxidative biomarkers MDA or 8-OH-dg were observed. AM HAT activities were not different between groups (10.1 ± 9.5 _versus_ 8.7 ± 5.5 for severe _versus_ moderate

asthma, _p_ = 0.657). However, AM HDAC activities were significantly blunted in children with severe asthma, suggesting increased inflammatory gene transcription (Fig. 2). IL-8 was also

significantly up-regulated in AMs from children with severe asthma (Fig. 2) and further correlated with AM HDAC activity (_r_ = −0.618, _p_ = 0.006) and IL-8 concentrations in the BAL

supernatant (_r_ = 0.830, _p_ < 0.001) and ELF (_r_ = 0.748, _p_ = 0.002). AM FUNCTION AND EFFECT OF GSH SUPPLEMENTATION. In children with severe asthma, the shift in the ratio of AM

intracellular GSH to GSSG was accompanied by impairment of AM function. Compared with children with moderate asthma, children with severe asthma had significantly blunted phagocytosis of _S.

aureus_ and increased apoptosis as measured by cleavage of PARP-1 (Fig. 2). The degree of AM phagocytic impairment was strongly associated with absolute GSSG concentrations and the

percentage of GSSG in the total GSH + GSSG pool in both the ELF and within the AM intracellular space (Fig. 3). AM apoptosis also correlated with ELF GSSG concentrations (_r_ = 0.310, _p_ =

0.05) and the percentage of ELF GSSG (_r_ = 0.451, _p_ = 0.035). _Exvivo_ supplementation with 500 μm GSH, a physiologically relevant concentration of GSH that is commonly observed in the

ELF of healthy controls (4), significantly increased AM phagocytosis and reduced AM apoptosis in children with severe asthma (Fig. 4). In children with severe asthma (_n_ = 5), GSH

supplementation further reduced intracellular GSSG as reflected by a significant decrease in GSH protein complexes (8627 ± 505 RFU _versus_ 5574 ± 766 RFU for baseline _versus_ GSH, _p_ =

0.015). DISCUSSION This study is the first to quantify the relationship between extracellular and intracellular GSH homeostasis and AM function in children with severe asthma. Although

extracellular GSH concentrations were not different in the airways of children with moderate and severe asthma, children with severe asthma had significantly higher GSSG concentrations

accompanied by increased lipid peroxidation and increased by-products of DNA oxidation in the extracellular space. This shift in the airway GSH to GSSG ratio was also mirrored within the AMs

and was further associated with AM functional disturbances, including decreased suppression of histone acetylation, impairment of phagocytosis, and increased apoptosis. _Exvivo_

supplementation with GSH improved phagocytosis and decreased apoptosis in children with severe asthma while also decreasing intracellular GSSG, suggesting that airway GSH and GSSG are the

primary regulators of AM function in these children. Thus, airway GSH homeostasis may represent a novel target for therapeutic intervention in children with severe asthma. GSH is a

tripeptide thiol that is essential for defense against oxidative damage and function of airway cells. Depletion of GSH through either a shift in the ratio of GSH to GSSG or a reduction in

the total GSH + GSSG pool results in activation of nuclear factor kappa B (NF-kappaB) and pro-inflammatory cytokine release from HDAC suppression and increased gene transcription (8,20). GSH

depletion has also been linked to increased AM apoptosis from caspase activation and PARP degradation (21) and to impaired phagocytosis of infectious particles (22), perhaps through

inhibition of the transcription factor, NF-E2-related factor 2 (Nrf2) (11). Although molecular mechanisms of altered GSH homeostasis have not been studied in patients with asthma, our

findings of increased intracellular GSSG and corresponding AM dysfunction in the form of decreased HDAC activity, increased apoptosis, and impaired phagocytosis suggest that GSH and perhaps

NF-kappaB and Nrf2 may regulate many features of the disorder. Indeed, in murine models of allergic airway inflammation, GSH attenuates airway hyperresponsiveness and the airway Th2

imbalance through suppression of chemokine-induced eosinophil chemotaxis and inhibition of NF-kappaB (9,23,24). Similarly, although Nrf2-deficient mice have increased susceptibility to acute

lung injury, GSH supplementation prevents lung injury in Nrf2-deficient mice by inhibiting the recruitment of inflammatory cells to the site of airway injury (25). These data highlight the

important role of GSH in the airways and argue for additional study of the mechanisms of GSH-related airway dysfunction in severe asthma. Although we did not observe differences in ELF GSH

concentrations between children with moderate and severe asthma in this study (∼30 μm in each group), these levels are significantly lower than those previously reported in healthy adults

(500 μm) and in our previous studies of nonasthmatic children with chronic cough (250 μm) (2,4). Although it is possible that these decreased GSH concentrations are due to a defect in

GSH-related enzymatic activities or polymorphisms in GSH transferases, we recently observed no differences in the activity of GSH peroxidase, GSH-S-transferase, or GSH reductase between

children with moderate and severe asthma and healthy controls (2). Thus, the GSH concentrations that we observed here are likely related to chronic airway oxidation and diffuse airway

injury. Indeed, the ELF GSH concentrations that we observed in children with moderate and severe asthma are consistent with those of adults with acute respiratory distress syndrome, a

disorder associated with diffuse alveolar injury (26,27). Although asthma is traditionally thought to affect the bronchial _versus_ the alveolar airspaces, there is increasing evidence of

distal airway inflammation in both humans (28,29) and in experimental models of asthma (30). Although our BAL samples were pooled and do include a mixture of both bronchial and lower airway

constituents, our data may reflect early distal airway damage in moderate to severe asthmatic children that is reflected by low GSH concentrations and altered GSH homeostasis. This study

does have limitations. Because, it is not ethical to perform bronchoscopy for research purposes in healthy children, it is unclear how our findings relate to steroid-naïve children with mild

asthma or children with mild asthma that is well controlled with low doses of ICS. Furthermore, it is possible that intracellular and extracellular GSH and GSSG concentrations and AM

function could be influenced by asthma treatment. However, we do not believe that corticosteroid use sufficiently explains the discrepancies observed in this study. Given the magnitude of

symptoms in children with moderate asthma, all children in this study were treated with ICS. Furthermore, there were no significant correlations between corticosteroid usage and the

oxidative and AM functional parameters measured in this study. In summary, severe asthma in children is a complicated disorder with persistent airway inflammation and ongoing symptoms that

are refractory to treatment with high doses of inhaled and oral corticosteroids. This airway inflammation is further accompanied by AM cellular dysfunction, including increased apoptosis and

impaired AM phagocytosis of infectious particles. Our findings of altered intracellular and extracellular airway GSH homeostasis provide a possible mechanism for these alterations. Given

the vital role of GSH in airway antioxidant defense and cellular function, airway GSH warrants further study in children with severe asthma. Interventions to improve airway GSH homeostasis

may ultimately be needed to decrease the morbidity of severe asthma in children. ABBREVIATIONS * 8-OH-dg: 8-hydroxy-2-deoxyguanosine * AM: airway macrophage * BAL: bronchoalveolar lavage *

ELF: epithelial lining fluid * GSH: glutathione (reduced form) * GSSG: glutathione disulfide (oxidized form) * HAT: histone acetyltransferase * HDAC: histone deacetylase * ICS: inhaled

corticosteroid * MDA: malondialdehyde * PARP: poly (ADP-ribose) polymerase REFERENCES * Fitzpatrick AM, Gaston BM, Erzurum SC, Teague WG 2006 Features of severe asthma in school-age

children: atopy and increased exhaled nitric oxide. _J Allergy Clin Immunol_ 118: 1218–1225 Article  CAS  Google Scholar  * Fitzpatrick AM, Teague WG, Holguin F, Yeh M, Brown LA, Severe

Asthma Research Program 2009 Airway glutathione homeostasis is altered in children with severe asthma: evidence for oxidant stress. _J Allergy Clin Immunol_ 123: 146–152.e8 Article  CAS 

Google Scholar  * Comhair SA, Ricci KS, Arroliga M, Lara AR, Dweik RA, Song W, Hazen SL, Bleecker ER, Busse WW, Chung KF, Gaston B, Hastie A, Hew M, Jarjour N, Moore W, Peters S, Teague WG,

Wenzel SE, Erzurum SC 2005 Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma. _Am J Respir Crit Care Med_ 172: 306–313 Article  Google Scholar  *

Cantin AM, North SL, Hubbard RC, Crystal RG 1987 Normal alveolar epithelial lining fluid contains high levels of glutathione. _J Appl Physiol_ 63: 152–157 Article  CAS  Google Scholar  *

Rahman I, Mulier B, Gilmour PS, Watchorn T, Donaldson K, Jeffery PK, MacNee W 2001 Oxidant-mediated lung epithelial cell tolerance: the role of intracellular glutathione and nuclear

factor-kappab. _Biochem Pharmacol_ 62: 787–794 Article  CAS  Google Scholar  * Rahman I, Yang SR, Biswas SK 2006 Current concepts of redox signaling in the lungs. _Antioxid Redox Signal_ 8:

681–689 Article  CAS  Google Scholar  * Kloek J, Mortaz E, van Ark I, Lilly CM, Nijkamp FP, Folkerts G 2010 Glutathione prevents the early asthmatic reaction and airway hyperresponsiveness

in guinea pigs. _J Physiol Pharmacol_ 61: 67–72 CAS  PubMed  Google Scholar  * Rahman I, Gilmour PS, Jimenez LA, MacNee W 2002 Oxidative stress and tnf-alpha induce histone acetylation and

nf-kappab/ap-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. _Mol Cell Biochem_ 234–235: 239–248 * Koike Y, Hisada T, Utsugi M,

Ishizuka T, Shimizu Y, Ono A, Murata Y, Hamuro J, Mori M, Dobashi K 2007 Glutathione redox regulates airway hyperresponsiveness and airway inflammation in mice. _Am J Respir Cell Mol Biol_

37: 322–329 Article  CAS  Google Scholar  * Corradi M, Folesani G, Andreoli R, Manini P, Bodini A, Piacentini G, Carraro S, Zanconato S, Baraldi E 2003 Aldehydes and glutathione in exhaled

breath condensate of children with asthma exacerbation. _Am J Respir Crit Care Med_ 167: 395–399 Article  Google Scholar  * Reddy NM, Suryanarayana V, Kalvakolanu DV, Yamamoto M, Kensler TW,

Hassoun PM, Kleeberger SR, Reddy SP 2009 Innate immunity against bacterial infection following hyperoxia exposure is impaired in nrf2-deficient mice. _J Immunol_ 183: 4601–4608 Article  CAS

  Google Scholar  * Fitzpatrick AM, Holguin F, Teague WG, Brown LA 2008 Alveolar macrophage phagocytosis is impaired in children with poorly controlled asthma. _J Allergy Clin Immunol_ 121:

1372–1378, 1378.e1–e3 Article  CAS  Google Scholar  * National Asthma Education and Prevention Program 2007 Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of

asthma-summary report 2007. _J Allergy Clin Immunol_ 120: S94–S138 Article  Google Scholar  * Wenzel SE, Fahy JV, Irvin C, Peters SP, Spector S, Szefler SJ, for the American Thoracic Society

Workshop 2000 Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. _Am J Respir Crit Care Med_

162: 2341–2351 Article  Google Scholar  * Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC,

MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J 2005 Standardisation of spirometry. _Eur Respir J_ 26: 319–338 Article  CAS  Google Scholar  * Wang X, Dockery

DW, Wypij D, Fay ME, Ferris BG Jr 1993 Pulmonary function between 6 and 18 years of age. _Pediatr Pulmonol_ 15: 75–88 Article  Google Scholar  * Jones DP, Carlson JL, Samiec PS, Sternberg P

Jr, Mody VC Jr, Reed RL, Brown LA 1998 Glutathione measurement in human plasma. Evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by

HPLC. _Clin Chim Acta_ 275: 175–184 Article  CAS  Google Scholar  * Rennard SI, Basset G, Lecossier D, O'Donnell KM, Pinkston P, Martin PG, Crystal RG 1986 Estimation of volume of

epithelial lining fluid recovered by lavage using urea as marker of dilution. _J Appl Physiol_ 60: 532–538 Article  CAS  Google Scholar  * Reed DJ, Babson JR, Beatty PW, Brodie AE, Ellis WW,

Potter DW 1980 High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfides. _Anal Biochem_ 106: 55–62 Article

  CAS  Google Scholar  * Yang SR, Chida AS, Bauter MR, Shafiq N, Seweryniak K, Maggirwar SB, Kilty I, Rahman I 2006 Cigarette smoke induces proinflammatory cytokine release by activation of

nf-kappab and posttranslational modifications of histone deacetylase in macrophages. _Am J Physiol Lung Cell Mol Physiol_ 291: L46–L57 Article  CAS  Google Scholar  * Hu S, Zhao H, Al-Humadi

NH, Yin XJ, Ma JK 2006 Silica-induced apoptosis in alveolar macrophages: evidence of in vivo thiol depletion and the activation of mitochondrial pathway. _J Toxicol Environ Health A_ 69:

1261–1284 Article  CAS  Google Scholar  * Brown LA, Ping XD, Harris FL, Gauthier TW 2007 Glutathione availability modulates alveolar macrophage function in the chronic ethanol-fed rat. _Am J

Physiol Lung Cell Mol Physiol_ 292: L824–L832 Article  CAS  Google Scholar  * Lee KS, Kim SR, Park HS, Park SJ, Min KH, Lee KY, Choe YH, Hong SH, Han HJ, Lee YR, Kim JS, Atlas D, Lee YC

2007 A novel thiol compound, n-acetylcysteine amide, attenuates allergic airway disease by regulating activation of nf-kappab and hypoxia-inducible factor-1alpha. _Exp Mol Med_ 39: 756–768

Article  CAS  Google Scholar  * Lowry MH, McAllister BP, Jean JC, Brown LA, Hughey RP, Cruikshank WW, Amar S, Lucey EC, Braun K, Johnson P, Wight TN, Joyce-Brady M 2008 Lung lining fluid

glutathione attenuates il-13-induced asthma. _Am J Respir Cell Mol Biol_ 38: 509–516 Article  CAS  Google Scholar  * Reddy NM, Kleeberger SR, Kensler TW, Yamamoto M, Hassoun PM, Reddy SP

2009 Disruption of nrf2 impairs the resolution of hyperoxia-induced acute lung injury and inflammation in mice. _J Immunol_ 182: 7264–7271 Article  CAS  Google Scholar  * Bunnell E, Pacht ER

1993 Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome. _Am Rev Respir Dis_ 148: 1174–1178 Article  CAS  Google Scholar  *

Schmidt R, Luboeinski T, Markart P, Ruppert C, Daum C, Grimminger F, Seeger W, Gunther A 2004 Alveolar antioxidant status in patients with acute respiratory distress syndrome. _Eur Respir J_

24: 994–999 Article  CAS  Google Scholar  * Balzar S, Chu HW, Strand M, Wenzel S 2005 Relationship of small airway chymase-positive mast cells and lung function in severe asthma. _Am J

Respir Crit Care Med_ 171: 431–439 Article  Google Scholar  * Fitzpatrick AM, Brown LA, Holguin F, Teague WG, National Institutes of Health/National Heart, Lung, and Blood Institute Severe

Asthma Research Program 2009 Levels of nitric oxide oxidation products are increased in the epithelial lining fluid of children with persistent asthma. _J Allergy Clin Immunol_ 124: 990–996.

e1–e9 Article  CAS  Google Scholar  * Wegmann M, Fehrenbach H, Fehrenbach A, Held T, Schramm C, Garn H, Renz H 2005 Involvement of distal airways in a chronic model of experimental asthma.

_Clin Exp Allergy_ 35: 1263–1271 Article  CAS  Google Scholar  Download references ACKNOWLEDGEMENTS The Severe Asthma Research Program (SARP) is a multicenter asthma research group funded by

the NHLBI and consisting of the following contributors (Principal Investigators are marked with an asterisk): Brigham & Women's Hospital—Elliot Israel*, Bruce D. Levy, Michael E.

Wechsler, Shamsah Kazani, and Gautham Marigowda; Cleveland Clinic—Serpil C. Erzurum*, Raed A. Dweik, Suzy A.A. Comhair, Emmea Cleggett-Mattox, Deepa George, Marcelle Baaklini, and Daniel

Laskowski; Emory University—Anne M. Fitzpatrick, Denise Whitlock, and Shanae Wakefield; Imperial College School of Medicine—Kian Fan Chung*, Mark Hew, Patricia Macedo, Sally Meah, and

Florence Chow; University of Iowa—Eric Hoffman*, Janice Cook-Granroth; University of Pittsburgh—Sally E. Wenzel*, Fernando Holguin, Silvana Balzar, and Jen Chamberlin; University of

Texas-Medical Branch—William J. Calhoun* and Bill T. Ameredes; University of Virginia—Benjamin Gaston*, W. Gerald Teague*, and Denise Thompson-Batt; University of Wisconsin—William W.

Busse*, Nizar Jarjour, Ronald Sorkness, Sean Fain, and Gina Crisafi; Wake Forest University—Eugene R. Bleecker*, Deborah Meyers, Wendy Moore, Stephen Peters, Rodolfo M. Pascual, Annette

Hastie, Gregory Hawkins, Jeffrey Krings, and Regina Smith; Washington University in St. Louis—Mario Castro*, Leonard Bacharier, and Jaime Tarsi; Data Coordinating Center—Douglas

Curran-Everett*, Ruthie Knowles, Maura Robinson, and Lori Silveira; NHLBI—Patricia Noel, Robert Smith. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department of Pediatrics, Emory

University School of Medicine, Atlanta, 30322, Georgia Anne M Fitzpatrick, W Gerald Teague, Leandrea Burwell, Meredith S Brown & Lou Ann S Brown Authors * Anne M Fitzpatrick View author

publications You can also search for this author inPubMed Google Scholar * W Gerald Teague View author publications You can also search for this author inPubMed Google Scholar * Leandrea

Burwell View author publications You can also search for this author inPubMed Google Scholar * Meredith S Brown View author publications You can also search for this author inPubMed Google

Scholar * Lou Ann S Brown View author publications You can also search for this author inPubMed Google Scholar CONSORTIA FOR THE NIH/NHLBI SEVERE ASTHMA RESEARCH PROGRAM ADDITIONAL

INFORMATION Supported by Grants KO1 NR010548, RO1 HL69170, the Children's Healthcare of Atlanta Center for Developmental Lung Biology, and Grant UL1 RR025008 from the Clinical and

Translational Science Award Program RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Fitzpatrick, A., Teague, W., Burwell, L. _et al._ Glutathione

Oxidation Is Associated With Airway Macrophage Functional Impairment in Children With Severe Asthma. _Pediatr Res_ 69, 154–159 (2011). https://doi.org/10.1203/PDR.0b013e3182026370 Download

citation * Received: 27 May 2010 * Accepted: 09 September 2010 * Issue Date: February 2011 * DOI: https://doi.org/10.1203/PDR.0b013e3182026370 SHARE THIS ARTICLE Anyone you share the

following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer

Nature SharedIt content-sharing initiative